In the context of Non-Target Organisms (NTOs) gaining increasing relevance in the field of agricultural biotechnology, ...
Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...
16h
Sinar Daily on MSNRetort technology allows nasi impit to last up to a yearBy using the technology, the company can now produce more than 500 packs of nasi impit daily, including for the Singapore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results